Assessment using the Beck Anxiety Inventory (BAI) and Centre for Epidemiologic Studies Depression scale (CESD) showed no evidence of APOE genotype disclosure resulting in adverse psychological outcomes [194]. Here, APOE is linked to depressive symptom measurement.